La industria farmaceútica, las categorías clínicas en salud mental y los médicos agotados
Bernstein, Jorge.
Evid. actual. práct. ambul
; 7(5): 130-131, sept.-oct. 2004.
Artigo em Espanhol | LILACS | ID: lil-516179
Documentos relacionados
The role of pharmaceutical side-effects in depression among immigrants.
Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs.
Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods.
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.
Ketamine as a Novel Drug for Depression Treatment.
Effects of Discontinuation of Drugs Used for Augmentation Therapy on Treatment Outcomes in Depression: A Systematic Review and Meta-analysis.
Unlocking the secrets of doxepin hydrochloride's crystal structure: Insights from high-quality powder diffraction analysis.
Decarboxylative Borylation and Cross-Coupling of (Hetero)aryl Acids Enabled by Copper Charge Transfer Catalysis.
Early Assessment of Biodegradability of Small Molecules to Support the Chemical Design in Agro & Pharma R&D.
Ionic Liquids: New Forms of Active Pharmaceutical Ingredients with Unique, Tunable Properties.